The Berkeley China Initiative: Venture Capital in China
The Berkeley China Initiative brings together the exceptional resources that UC Berkeley offers across the disciplines and professions to strengthen research and teaching about China, forge new international partnerships, and enrich public life by communicating those results. Sponsored by the University of California, Berkeley, and International & Area Studies. [events] [glopubaffairs] [bci] Credits: producer:UC Berkeley Educational Technology Services, sponsor:International & Area Studies, speaker:Daniel Scheinman - Cisco Systems
eCHEM 1A: Online General Chemistry
College of Chemistry, University of California, Berkeley
http://chemistry.berkeley.edu/echem1a
Curriculum and ChemQuizzes developed by Dr. Mark Kubinec and Professor Alexander Pines
Chemical Demonstrations by Lonnie Martin
Video Production by Jon Schainker and Scott Vento
Developed with the support of The Camille & Henry Dreyfus Foundation
"Measuring 'Nothing' and Getting It Right" - a symposium in honor of the physics career of Dr. Stuart Freedman (http://freedman2014.org): Dr. Tony Nero (Environmental Energy Technologies Division, Lawrence Berkeley National Laboratory) speaks about Dr. Stuart Freedman's 1972 experiment (with Dr. John Clauser). The theory of "hidden variables" is discussed, including its motivation, conduct, and results, as well as factors affecting how credit was apportioned for its success.
Economics C3, 001 - Fall 2014
Introduction to Environmental Economics and Policy - Peter Berck
Creative Commons 3.0: Attribution-NonCommercial-NoDerivs
2014 Diagnostics by Design Workshop Day
Hosted by the PoCDx IdeaLab (http://pocdx.org), Tekla Labs (http://www.teklalabs.org), and the Center for Emerging and Neglected Diseases (http://cend.globalhealth.berkeley.edu/)
"Career Lesons -- From the IVD Industry to the Bill & Melinda Gates Foundation"
Jim Gallarda, Senior Program Officer, Diagnostics, Bill & Melinda Gates Foundation
Talk abstract:
In this one hour overview Jim Gallarda will discuss & compare his experiences while at Abbott and Roche working on infectious disease diagnostics, to those he had while working in oncology companion diagnostics at Novartis Pharmaceuticals, to his current role as a Program Officer at the Bill & Melinda Gates Foundation. Formal IVD development processes will be emphasized, with a comparison of for-profit industry vs. not-for-profit NGOs (such as the Foundation), along with a few professional "life lessons" he wish he had learned much earlier.
...